| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,196 |
5,857 |
$494K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,350 |
3,232 |
$172K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,631 |
1,630 |
$134K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,291 |
1,289 |
$107K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,216 |
1,202 |
$104K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
625 |
624 |
$57K |
| 99215 |
Prolong outpt/office vis |
417 |
388 |
$49K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
726 |
708 |
$27K |
| 99051 |
|
874 |
867 |
$24K |
| 87428 |
|
717 |
707 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,315 |
1,289 |
$20K |
| 99188 |
|
766 |
763 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,104 |
548 |
$14K |
| 90686 |
|
984 |
972 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
69 |
66 |
$2K |
| 90670 |
|
596 |
596 |
$2K |
| 90648 |
|
874 |
870 |
$2K |
| 90633 |
|
411 |
410 |
$1K |
| 90723 |
|
539 |
537 |
$1K |
| 0071A |
|
19 |
19 |
$836.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
37 |
35 |
$714.10 |
| 0072A |
|
27 |
27 |
$660.00 |
| 92551 |
|
1,267 |
1,267 |
$572.06 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
793 |
787 |
$551.98 |
| 96127 |
|
987 |
985 |
$550.50 |
| 90680 |
|
405 |
403 |
$504.00 |
| 81002 |
|
136 |
134 |
$461.01 |
| 99177 |
|
866 |
866 |
$437.08 |
| 96160 |
|
962 |
960 |
$374.64 |
| 99173 |
|
287 |
287 |
$207.35 |
| 90651 |
|
312 |
312 |
$143.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$122.00 |
| 85018 |
|
51 |
51 |
$20.22 |
| G9920 |
Screening performed and negative |
864 |
864 |
$0.00 |
| 83655 |
|
25 |
25 |
$0.00 |
| 90715 |
|
28 |
28 |
$0.00 |
| 90710 |
|
41 |
41 |
$0.00 |
| 90707 |
|
14 |
14 |
$0.00 |
| 90661 |
|
102 |
102 |
$0.00 |
| 90620 |
|
27 |
27 |
$0.00 |
| 96161 |
|
811 |
806 |
$0.00 |
| 90677 |
|
300 |
296 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
358 |
353 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.00 |
| 90619 |
|
76 |
76 |
$0.00 |
| 90656 |
|
134 |
134 |
$0.00 |
| 90716 |
|
37 |
37 |
$0.00 |
| 90696 |
|
42 |
42 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
14 |
$0.00 |